Frequently Asked Questions About WuXi AppTec

Last Updated: May 2026

Company Overview & Business Model

Q1: What is WuXi AppTec?

A: WuXi AppTec is a global contract research, development, and manufacturing organization (CRDMO) serving the pharmaceutical and life sciences industries. Founded in 2000, WuXi AppTec works with companies of all sizes around the world — from emerging biotech startups to leading multinational pharmaceutical firms — across more than 30 countries to help bring life-saving or life-improving medicines and therapies to patients.

Q2: What is WuXi AppTec's CRDMO Model?

A: WuXi AppTec's CRDMO model integrates contract research, development and manufacturing into a single platform, enabling innovators to move faster, lower costs, and improve the likelihood of success. Across our three business segments – WuXi Chemistry, WuXi Biology, and WuXi Testing – this integrated model streamlines the end-to-end drug development journey, eliminates handoffs and reduces delays, while ensuring unwavering quality.

Q3: What benefits does the CRDMO model bring to drug innovators?

A: For biotechs, our CRDMO model enables faster pipeline advancement and greater equity value creation. For large pharma, it streamlines R&D to replenish pipelines more efficiently. For patients, it translates to faster access, more affordable treatments, and greater hope.

Q4: What services does WuXi AppTec provide?

A: WuXi AppTec provides integrated drug discovery, development and manufacturing services across three business segments: WuXi Chemistry, WuXi Biology, and WuXi Testing.

WuXi Chemistry: CRDMO services from drug discovery to commercial manufacturing, covering all synthetic molecular modalities – small molecules, oligonucleotides, peptides and complex conjugates.
WuXi Biology: Biology services and solutions supporting standalone and integrated projects, from target discovery to candidate selection and clinical entry.
WuXi Testing: Integrated testing services across the full drug discovery and development lifecycle.

Q5: Where is WuXi AppTec located?

A: WuXi AppTec is a global company with operations across Asia, Europe, and North America, including China, Singapore, Japan, South Korea, Germany, Switzerland, and the United States.

Q6：What role does WuXi AppTec play in the pharmaceutical supply chain?

A: WuXi AppTec is a trusted partner to global customers across more than 30 countries, and its facilities across Asia, Europe and the U.S. enable customers to develop and deliver medicines and therapies to patients worldwide. WuXi AppTec is one of many contract service organizations supporting the global pharmaceutical and life sciences industries and has no exclusive service agreements with its customers, allowing them to work with multiple suppliers and maintain supply chain resilience.

Data Security, Privacy and Regulatory Oversight

Q7: How does WuXi AppTec maintain customer trust?

A: Intellectual property (IP) protection is at the heart of WuXi AppTec's business model, and is a foundation of the trust WuXi AppTec has built with customers since its founding in 2000.

Q8: What data privacy and intellectual property laws and guidelines govern WuXi AppTec's operations?

A: WuXi AppTec strictly adheres to all applicable data and IP protection laws, regulations, and industry standards in jurisdictions in which it operates. In the U.S., this includes guidelines set by the U.S. Department of Health & Human Services, Federal Trade Commission, and Food & Drug Administration. In addition, WuXi AppTec's customers conduct regular inspections on us: in 2025, we completed 60 customer information security audits, with a 100% pass rate and no critical findings.

Q9: What measures does WuXi AppTec use to protect customer data and intellectual property?

A: All project data is compartmentalized by customer and accessible only to authorized personnel. All U.S.-based project information is stored exclusively in U.S.-based facilities and IT systems, separated by robust firewalls from operations in other countries.

Q10: How does the company ensure quality, regulatory compliance, and information security across its global operations?

A: WuXi AppTec consistently adheres to the highest global quality standards and strictly maintains a robust quality audit program that covers all main operational sites and functions to drive the continuous improvement of Quality Management System (QMS). In 2025, WuXi AppTec passed 741 quality audits and inspections conducted by global customers, regulatory authorities and independent third parties, as well as 60 information security audits by global customers, all with no critical findings. All of our main sites are ISO/IEC 27001 certified.

Corporate Governance & Business Scope

Q11: What is WuXi AppTec's ownership structure?

A: WuXi AppTec is a publicly traded commercial enterprise with a diverse global shareholder base, including leading institutional investors from the United States, Europe, Asia, and the Middle East. As a public company, we owe fiduciary duties to create value for shareholders through transparent, market-driven operations.

Q12: Who leads WuXi AppTec?

A: WuXi AppTec is managed by its board of directors and senior executive management team. They comprise established scientists and business professionals with no military background or political party affiliation.

Q13: Is WuXi AppTec a Chinese Military Company?

A: No. WuXi AppTec is not a Chinese military company.

WuXi AppTec does not meet the statutory criteria for designation as a "Chinese military company" under the applicable US laws.
WuXi AppTec is not owned or controlled by, or affiliated with, any PRC military or government authority.
WuXi AppTec does not provide services to the PRC military; and the company is not associated with the PRC’s defense industrial base or military-civil fusion programs.

Q14: Has WuXi AppTec ever been placed on a U.S. government sanctions list?

A: WuXi AppTec has never been placed on any effective government sanctions list in the U.S. or any other country.

Q15: Does WuXi AppTec do gene sequencing?

A: No. WuXi AppTec does not do human gene sequencing. WuXi AppTec does not have a human genomics business or collect or deal with human genomic data.

Q16: Does WuXi AppTec have cell and gene therapy (CGT) business?

A: WuXi AppTec sold its cell and gene therapy businesses to Altaris in March 2025, and is no longer involved in this area.

Q17: Where can I learn more about WuXi AppTec?

A: Visit the following resources for more information about WuXi AppTec: